A collaborative epidemiological investigation into the criminal fake artesunate trade in South East Asia

Newton, P; Fernández, F; Plançon, A; Mildenhal, D; Green, MD; Ziyong, L; Christophel, E; Phanouvong, S; Howells, S; McIntosh, E; Laurin, P; Blum, N; Hampton, C; Faure, K; Nyadong, L; Soong, C; Santoso, B; Zhiguang, W; Newton, J; Palmer, K

Journal article

A collaborative epidemiological investigation into the criminal fake artesunate trade in South East Asia

Abstract:: Background: Since 1998 the serious public health problem in South East Asia of counterfeit artesunate, containing no or subtherapeutic amounts of the active antimalarial ingredient, has led to deaths from untreated malaria, reduced confidence in this vital drug, large economic losses for the legitimate manufacturers, and concerns that artemisinin resistance might be engendered. Methods and Findings: With evidence of a deteriorating situation, a group of police, criminal analysts, chemists, palynologists, and health workers collaborated to determine the source of these counterfeits under the auspices of the International Criminal Police Organization (INTERPOL) and the Western Pacific World Health Organization Regional Office. A total of 391 samples of genuine and counterfeit artesunate collected in Vietnam (75), Cambodia (48), Lao PDR (115), Myanmar (Burma) (137) and the Thai/Myanmar border (16), were available for analysis. Sixteen different fake hologram types were identified. High-performance liquid chromatography and/or mass spectrometry confirmed that all specimens thought to be counterfeit (195/391, 49.9%) on the basis of packaging contained no or small quantities of artesunate (up to 12 mg per tablet as opposed to ∼ 50 mg per genuine tablet). Chemical analysis demonstrated a wide diversity of wrong active ingredients, including banned pharmaceuticals, such as metamizole, and safrole, a carcinogen, and raw material for manufacture of methylenedioxymethamphetamine ('ecstasy'). Evidence from chemical, mineralogical, biological, and packaging analysis suggested that at least some of the counterfeits were manufactured in southeast People's Republic of China. This evidence prompted the Chinese Government to act quickly against the criminal traders with arrests and seizures. Conclusions: An international multi-disciplinary group obtained evidence that some of the counterfeit artesunate was manufactured in China, and this prompted a criminal investigation. International cross-disciplinary collaborations may be appropriate in the investigation of other serious counterfeit medicine public health problems elsewhere, but strengthening of international collaborations and forensic and drug regulatory authority capacity will be required. © 2008 Newton et al.

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Cite

Cite this record

APA Style

Newton, P., Fernández, F., Plançon, A., Mildenhal, D., Green, M. D., Ziyong, L., Christophel, E., Phanouvong, S., Howells, S., McIntosh, E., Laurin, P., Blum, N., Hampton, C., Faure, K., Nyadong, L., Soong, C., Santoso, B., Zhiguang, W., Newton, J., & Palmer, K. (2008). A collaborative epidemiological investigation into the criminal fake artesunate trade in South East Asia. PLoS Medicine, 5(2), 0209–0219.

MLA Style

Newton, P., et al. “A Collaborative Epidemiological Investigation into the Criminal Fake Artesunate Trade in South East Asia.” PLoS Medicine, vol. 5, no. 2, 2008, pp. 0209–19.

Chicago Style

Newton, P, F Fernández, A Plançon, D Mildenhal, MD Green, L Ziyong, E Christophel, et al. 2008. “A Collaborative Epidemiological Investigation into the Criminal Fake Artesunate Trade in South East Asia.” PLoS Medicine 5 (2): 0209–19.
Share
Print